NOVEL DOSAGE AND FORMULATION
First Claim
Patent Images
1. A pharmaceutical composition comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier wherein the pharmaceutical composition is capable of providing a metered nominal dose of aclidinium equivalent to about 400 micrograms aclidinium bromide, wherein the pharmaceutical composition is for inhalation.
1 Assignment
0 Petitions
Accused Products
Abstract
The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 400 micrograms aclidinium bromide.
-
Citations
28 Claims
- 1. A pharmaceutical composition comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier wherein the pharmaceutical composition is capable of providing a metered nominal dose of aclidinium equivalent to about 400 micrograms aclidinium bromide, wherein the pharmaceutical composition is for inhalation.
- 14. A method of treating a respiratory condition chosen from asthma and chronic obstructive pulmonary disease, comprising administering a dose of aclidinium equivalent to about 400 micrograms metered nominal dose of aclidinium bromide by inhalation to a patient in need of such treatment.
-
15. (canceled)
-
21-25. -25. (canceled)
-
26. A multidose dry powder inhaler device calibrated to deliver, upon actuation, a metered nominal dose of aclidinium equivalent to about 400 micrograms of aclidinium bromide.
Specification